FDTTX | VIVIX | FDTTX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 26 years | 27 years | - |
Gain YTD | 3.889 | 3.211 | 121% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.93B | 184B | 3% |
Annual Yield % from dividends | 0.92 | 2.37 | 39% |
Returns for 1 year | 22.22 | 18.21 | 122% |
Returns for 3 years | 24.96 | 18.46 | 135% |
Returns for 5 years | 59.02 | 44.19 | 134% |
Returns for 10 years | 84.74 | 111.13 | 76% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LEVOX | 4.30 | 0.04 | +0.94% |
Lazard US Equity Concentrated Open | |||
PAULX | 41.98 | 0.33 | +0.79% |
T. Rowe Price US Large-Cap Core Adv | |||
JDERX | 12.69 | 0.08 | +0.63% |
PGIM Jennison Mid-Cap Growth R | |||
HSMBX | 37.85 | 0.11 | +0.29% |
Horizon Multi-Factor Small/Mid Cap Adv | |||
GTORX | 36.82 | N/A | N/A |
Goldman Sachs Technology Opps R6 |